Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-22-000168 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
211.20% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 29th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.00% · OPTIONAL · VALID
Operating cash generation 86th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
41.11% · OPTIONAL · VALID
Share-count growth 80th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.shares_outstanding
40.93% · CORE · VALID
Revenue growth 100th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
78.89% · CORE · VALID
Inventory pressure 29th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
36.18% · OPTIONAL · VALID
Gross margin 29th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_margin
65.43% · CORE · VALID
Operating margin 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
30.89% · CORE · VALID
R&D intensity 0th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14.16% · OPTIONAL · VALID
SBC intensity 21th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.39% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 233.84%
Current 211.20%
Delta -22.64% Capex Intensity Decreased
Previous 4.14%
Current 4.00%
Delta -0.14% Cash Generation Increased
Previous 31.90%
Current 41.11%
Delta 9.21% Dilution Decreased
Previous 41.86%
Current 40.93%
Delta -0.93% Growth Increased
Previous 72.24%
Current 78.89%
Delta 6.65% Inventory Pressure Decreased
Previous 36.23%
Current 36.18%
Delta -0.05% Margin Increased
Previous 52.23%
Current 65.43%
Delta 13.20% Profitability Increased
Previous 13.59%
Current 30.89%
Delta 17.30% R And D Intensity Decreased
Previous 15.90%
Current 14.16%
Delta -1.74% Sbc Intensity Decreased
Previous 3.24%
Current 2.39%
Delta -0.85% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.